Today’s top gainers include the company Zoetis Inc. (NYSE:ZTS) which is in the industry Drugs – Generic, gaining -0.17% today. In the last week its performance is 1.28%, and 12.82% for the past quarter. Currently, Zoetis Inc., ZTS has a target price of 54.33, so today’s gain of -0.17% is a significant step towards its target price. The GAP today is therefore -0.27%.
Zoetis Inc. (NYSE:ZTS), has a market cap of 24987.87, and is based in USA. Insider ownership is at 0.01%, and institutional ownership is 91.30%.
At the current price of 51.98, it has a dividend yield of 0.73%, and its target price is 54.33. This is with a profit margin of 13.20%, and total debt/equity of *TBA. Zoetis Inc. (NYSE:ZTS) has a P/E of 68.78, as well as a forward P/E of 22.57.
With a current EPS of 0.76, and a forecasted EPS growth for next year at 21.74%,Zoetis Inc. (NYSE:ZTS) has had a EPS growth for the past five years at 25.10%. For the next five years EPS growth is projected to be 12.58%.
Performance for the year is 9.70%. Since its IPO date on 2/1/2013, the total performance to date is 9.35%.
Volume today for Zoetis Inc. (NYSE:ZTS), is 1980656, while its average volume is 3181.47. Whilst the total gain today was -0.17%, it did have a day high of -0.38%.
Volatility for this week has been at 1.40%, and 1.35% for the month. The 52-week low for Zoetis Inc., ZTS has been 38.91%, while the 52-week-high has reached -0.38%.
Looking at its return of investments, which is 5.70%, and its return on assets is *TBA. Zoetis Inc. (NYSE:ZTS) has an operating margin of 20.80%. With a sales growth of 2.80% quarter over quarter. Bearing in mind that Zoetis Inc., ZTS is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of Zoetis Inc.? Well its PEG is 5.47, and the P/S is 5.18, along with a P/B of 22.19. Meanwhile it has a p/cash of *TBA.